ArticleFrontiers in pharmacology2024

Comparing ischemic cardiovascular effectiveness and safety between individual SGLT-2 inhibitors and DPP-4 inhibitors in patients with type 2 diabetes: a nationwide population-based cohort study.

Hayeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.